M

Marinomed Biotech
MARI

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
€33.79M
EV
€61.36M
Shares Outstanding
1.78M
Beta
-0.08

Wall Street View

Analyst Rating
BUY
Analyst Target Price
€46.00
P/E 2025E
1.52x
P/Revenue 2025E
5.45x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Marinomed Biotech AG

gainify

M

Marinomed Biotech AG

MARI

Marinomed Biotech AG, a biopharmaceutical company, develops therapeutic products for indications in virology and immunology in Austria, other European countries, and internationally. It operates through Virology, Immunology, and Other segments. The company’s products ...

Sector

Healthcare

Industry

Biotechnology

CEO

Grassauer, Andreas

Employees

39

IPO Date

2019-02-01

Headquarters

Hovengasse 25, Korneuburg, Lower Austria, 2100, Austria

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.